Language: BG BG
← Back to results
Recruiting Not applicable NCT07537036

Analgesic Efficacy of Quadro-Iliac Plane Block Versus Erector Spinae Plane in Total Hip Arthroplasty

No applicable phase (e.g. observational)
Conditions: Analgesic Efficacy Quadro-Iliac Plane Block Erector Spinae Plane Block Total Hip Arthroplasty

Sponsor: Tanta University

trial.available_in: БГ
Overview
This study aims to compare the Quadro-Iliac Plane Block versus Erector Spinae Plane Block after total hip arthroplasty.
Description
Total hip arthroplasty (THA) is frequently utilized in elderly patients to address hip pain and restore joint function. Effective postoperative pain management is critical; however, the use of opioids is associated with a range of adverse effects, including nausea, vomiting, pruritus, constipation, respiratory depression, and the risk of dependence. Quadro-iliac plane block (QIPB) has been introduced, combining elements of both posterior and anterior QLB approaches. Erector Spinae Plane Block (ESPB) was initially described as an analgesic approach for managing thoracic neuropathic pain. This innovative fascial block technique enables sensory blockade across multiple abdominal and thoracic wall segments.
Who can participate
Inclusion Criteria: * Age ≥ 18 years. * Both sexes. * American Society of Anesthesiology (ASA) physical status I-III. * Undergoing total hip arthroplasty (THA) under spinal anesthesia. Exclusion Criteria: * History of allergies to local anesthetics. * Opioid dependency. * Body mass index (BMI) \> 35 kg/m2. * Cognitive impairment. * Bleeding or coagulation disorders. * Psychiatric and neurological disorder. * Local infection at the site of injection. * Severe heart, lung, liver, and renal dysfunction. * Emergency surgery.
Interventions
Quadro-iliac plane block
OTHER
Erector spinae plane block
OTHER
Locations 1
Egypt (1)
Tanta University
Tanta , El-Gharbia
Technical details
Status
Recruiting
Phase
Not applicable
Study type
INTERVENTIONAL
Sex
Male and female
Minimum age
18 Years
Healthy volunteers
No
Start date
18.04.2026
Completion date
01.10.2026
Registry ID
NCT07537036
Source
clinicaltrials.gov
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.